SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

02 Nov 2021 Evaluate
The sales for the September 2021 quarter moved down -30.62% to Rs. 101.74 millions as compared to Rs. 146.65 millions during the year ago period.Net profit was down at Rs. 2.76  millions against Rs. 21.54 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -87.19%.Operating profit for the quarter ended September 2021 decreased to 38.68 millions as compared to 59.87 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 101.74 146.65 -30.62 231.65 238.19 -2.75 517.75 553.52 -6.46
Other Income 0.24 0.00 0.00 2.44 0.00 0.00 0.79 0.53 49.06
PBIDT 38.68 59.87 -35.39 86.98 88.73 -1.97 177.43 125.24 41.67
Interest 10.64 10.30 3.30 19.24 17.34 10.96 35.29 30.98 13.91
PBDT 28.04 49.57 -43.43 67.74 71.39 -5.11 142.14 94.26 50.80
Depreciation 17.39 12.59 38.13 35.26 25.23 39.75 55.91 51.72 8.10
PBT 10.65 36.98 -71.20 32.48 46.16 -29.64 86.23 42.54 102.70
TAX 7.89 15.44 -48.90 17.40 14.84 17.25 29.37 -1.89 -1653.97
Deferred Tax 4.86 8.04 -39.55 9.32 5.61 66.13 15.79 -13.11 -220.44
PAT 2.76 21.54 -87.19 15.08 31.32 -51.85 56.86 44.43 27.98
Equity 142.04 128.87 10.22 142.05 128.88 10.22 134.19 128.88 4.12
PBIDTM(%) 38.02 40.83 -6.87 37.55 37.25 0.80 34.27 22.63 51.46

Vivo Bio Tech Share Price

29.30 0.38 (1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×